共 13 条
[1]
Bhat DJ, Tellis VA, Kohlberg WI, Driscoll B, Veith FJ, Management of sepsis involving expanded polytetrafluoroethylene grafts for hemodialysis access, Surgery, 87, pp. 445-450, (1980)
[2]
Goldman M, Vanherweghem J-L, Bacterial infections in chronic hemodialysis patients: Epidemiologic and pathophysiologic aspects, Adv Nephrol, 19, pp. 315-332, (1990)
[3]
Ingerman MJ, Santoro J, Vancomycin: A new old agent, Infect Dis Clin N Am, 3, pp. 641-651, (1989)
[4]
Ackerman BH, Vannier AM, Necessity of a loading dose when using vancomycin in critically ill patients, J Antimicrob Chemother, 29, pp. 460-461, (1992)
[5]
Moellering RC, Pharmacokinetics of vancomycin, J Antimicrob Chemother, 14, pp. 43-52, (1984)
[6]
Small PM, Chambers HF: Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users, Antimicrob Agents Chemother, 34, pp. 1227-1231, (1990)
[7]
Levine DP, Fromm BS, Reddy BR, Slow response to vancomycin or vancomycin plus rifampin in methicillin‐resistant Staphylococcus aureus endocarditis, Ann Intern Med, 115, pp. 674-680, (1991)
[8]
Lanese DM, Alfrey PS, Molitoris BA, Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers, Kidney Int, 35, pp. 1409-1412, (1989)
[9]
Chambers HF, Miller RT, Newman MD, Right‐sided Staphylococcus aureus endocarditis in intravenous drug abusers: Two‐week combination therapy, Ann Intern Med, 109, pp. 619-624, (1988)
[10]
Ehni WF, Reller LB, Short‐course therapy for catheter‐associated Staphylococcus aureus bacteremia, Arch Intern Med, 149, pp. 533-536, (1989)